Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | QPCT | Q16769 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.34 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.31 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8305506 | 0.87 | HTT (0.33) | NFKB1QPCTHSD17B10QPCTLTBXAS1 | |
| SCHEMBL6668516 | 0.73 | TBXAS1 (0.37) | NFKB1QPCTHSD17B10QPCTLTBXAS1 | |
| SCHEMBL5132791 | 0.71 | TBXAS1 (0.33) | NFKB1QPCTHSD17B10QPCTLTBXAS1 | |
| SCHEMBL6008500 | 0.71 | — | — | |
| SCHEMBL6398854 | 0.70 | EGLN3 (0.40) | TBXAS1CYP19A1AHR | |
| SCHEMBL29082466 | 0.68 | TBXAS1 (0.44) | NFKB1QPCTHSD17B10QPCTLTBXAS1 | |
| SCHEMBL12980246 | 0.67 | CYP19A1 (0.33) | NFKB1QPCTHSD17B10QPCTLHTT | |
| SCHEMBL28183020 | 0.67 | TBXAS1 (0.43) | NFKB1QPCTHSD17B10QPCTLTBXAS1 | |
| SCHEMBL28182996 | 0.66 | — | — | |
| SCHEMBL28458584 | 0.66 | EGLN3 (0.33) | TBXAS1AHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080312207-A1 | Compounds | SYNGENTA CROP PROTECTION AG (CH) | 2008-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312207-A1 | Compounds | GRK4, PTGER4, GRK5 | NFKB1 560/4885QPCT 3458/4885HSD17B10 776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.